![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Files Provisional Patent Application with United States Patent and Trademark Office (USPTO) -"Systems and Methods for Predicting Treatment-Regimen-Related Outcomes."
05 oct. 2015 08h00 HE
|
Inform Genomics
Boston, Oct. 5, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary analytic platform to develop genomic-based, precision medicine products announced...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Licenses Two US Patents from Taiwan's National Cheng Kung University to Advance Development of Precision Medicine Products
01 juin 2015 08h30 HE
|
Inform Genomics
Boston, MA, June 1, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a
proprietary analytic platform to develop genomic-based, precision
medicine products, and...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Selects ICON as Contract Research Organization (CRO) for Pivotal Multicenter Study of HSCT/Mucositis Product Candidate
01 juin 2015 08h00 HE
|
Inform Genomics
Boston, MA, June 1, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a
proprietary analytic platform to develop genomic-based, precision
medicine products, today...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Selects US Oncology Research as the Site Management Organization (SMO) for Pivotal Multicenter Study of OnPART
29 mai 2015 16h00 HE
|
Inform Genomics
Boston, MA, May 29, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a
proprietary analytic platform to discover and develop
genomic-based, precision medicine...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Selects Vector Oncology as Contract Research Organization (CRO) for Pivotal Multicenter Study of OnPART
29 mai 2015 08h00 HE
|
Inform Genomics
Boston, MA and Memphis, TN, May 29, 2015 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a
proprietary analytic platform to develop genomic-based, precision
medicine...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Announces Appointment of Carl de Moor, PhD, as Chief Technology Officer
28 juil. 2014 08h00 HE
|
Inform Genomics
Boston, MA, July 28, 2014 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc, a privately held company that utilizes a
proprietary technology platform to discover and develop
genomic-based, precision medicine...
Inform Genomics and Translational Drug Development (TD2) Announce Strategic Collaboration
23 juin 2014 07h00 HE
|
Inform Genomics
BOSTON, June 23, 2014 (GLOBE NEWSWIRE) -- Inform Genomics, Inc., a privately held company that utilizes a proprietary technology platform to discover and develop genomic-based, precision medicine...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
INFORM GENOMICS and TESARO Enter Into Collaboration Agreement
15 oct. 2013 07h00 HE
|
Inform Genomics
Boston, MA, Oct. 15, 2013 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based, personalized medicine products for
cancer supportive...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Presents Biologic Validity for OnPART Predictive Networks Identifying Potential Genomic Targets for Drug Discovery
03 juin 2013 08h00 HE
|
Inform Genomics
Boston, MA, June 3, 2013 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based personalized medicine products for
cancer supportive...
![Inform Genomics logo](/news-release/logo/345159/0/345159.jpg?lastModified=12%2F09%2F2016%2023%3A11%3A10&size=2)
Inform Genomics Presents Results for OnPART(tm) Showing High Degree of Accuracy Predicting Six Common Side Effects of FOLFOX Chemotherapy for Colon Cancer
28 janv. 2013 07h00 HE
|
Inform Genomics
Boston, MA, Jan. 28, 2013 (GLOBE NEWSWIRE) -- Inform
Genomics, Inc., a private company focused on developing novel
platforms of genomic-based personalized medicine products for
cancer supportive...